Regeneron Pharmaceuticals Inc (REGN)
Operating profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 4,047,100 | 4,221,000 | 4,333,700 | 4,427,100 | 4,738,900 | 6,231,800 | 6,855,300 | 9,092,600 | 8,946,800 | 7,474,100 | 6,680,000 | 3,989,200 | 3,576,600 | 3,085,300 | 2,770,700 | 2,429,900 | 2,209,800 | 2,252,200 | 2,140,600 | 2,447,200 |
Revenue (ttm) | US$ in thousands | 13,044,200 | 13,025,200 | 12,601,200 | 12,306,100 | 12,113,500 | 13,654,100 | 14,171,800 | 16,451,800 | 16,014,400 | 13,499,700 | 12,328,800 | 9,147,000 | 8,455,000 | 8,201,600 | 7,974,500 | 7,957,900 | 7,839,900 | 7,598,200 | 7,213,600 | 6,889,000 |
Operating profit margin | 31.03% | 32.41% | 34.39% | 35.97% | 39.12% | 45.64% | 48.37% | 55.27% | 55.87% | 55.36% | 54.18% | 43.61% | 42.30% | 37.62% | 34.74% | 30.53% | 28.19% | 29.64% | 29.67% | 35.52% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $4,047,100K ÷ $13,044,200K
= 31.03%
Regeneron Pharmaceuticals, Inc.'s operating profit margin has shown a declining trend over the past eight quarters, indicating potential challenges in managing operating expenses relative to revenue generation. The company's operating profit margin decreased from 55.10% in Q1 2022 to 32.26% in Q4 2023. This downward trajectory suggests a decrease in the efficiency of converting revenue into profits, which could be attributed to factors such as rising costs or pricing pressures in the pharmaceutical industry. It is important for the company to closely monitor and address the underlying factors driving this decline to ensure sustainable profitability and operational efficiency in the future.
Peer comparison
Dec 31, 2023
See also:
Regeneron Pharmaceuticals Inc Operating Profit Margin (Quarterly Data)